Product Information |
Synonym(s) |
PR-171, proteasome inhibitor |
Chemical Name |
(αS)-α-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]- L-phenylalaninamide |
Application |
Carfilzomib is an irreversible proteasome inhibitor |
CAS Number |
868540-17-4 |
Purity |
≥99.0% |
Molecular Weight |
719.91 |
Molecular Formula |
C₄₀H₅₇N₅O₇ |
SMILES |
CC(C)C[C@@H](C(=O)[C@]1(CO1)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC3=CC=CC=C3)NC(=O)CN4CCOCC4 |
Target & IC50 |
Proteasome: IC50 = 5nM |
Solubility |
DMSO: 100 mg/mL (138.91 mM) |
Preparing Stock Solutions |
ConcentrationSolventMass |
1 mg |
5 mg |
10 mg |
1 mM |
1.3891 ml |
6.9453 ml |
13.8906 ml |
5 mM |
0.2778 ml |
1.3891 ml |
2.7781 ml |
10 mM |
0.1389 ml |
0.6945 ml |
1.3891 ml |
50 mM |
0.0278 ml |
0.1389 ml |
0.2778 ml |
|
Shipping |
Gel Pack |
Storage |
Store at -20°C |
Research Use |
For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. |